Vagus Nerve Stimulator Market

DelveInsigth’s Vagus Nerve Stimulator market report provides an overview of Vagus Nerve Stimulators, as well as reasons to purchase Vagus Nerve Stimulators, as well as its benefits and limitations. Furthermore, the report provides information on the market share of individual VNS devices, as well as the current and forecasted VNS market size from 2018 to 2026, segmented into 7MM (the United States, EU5 (Germany, France, Spain, Italy, and the United Kingdom), and Japan).

Some of the Key Highlights from the Vagus Nerve Stimulator Market Report

• According to Delveinsight’s analysis, 52,063 patients in the United States with Drug-Resistant Epilepsy were eligible for Vagus Nerve Stimulator therapy in 2018.

• The United States had the largest eligible patient population for the Vagus Nerve Stimulator device, suffering from treatment-resistant depression.

• Key MedTech companies in the Vagus Nerve Stimulator market include Electrocore Inc., tVNS Technologies, LivaNova, Soterix Medical, NeuroSigma, ReShape Lifesciences, NeuroPace, Inc., Micro Transponder, SetPoint Medical Corporation, Neuroceuticals, Parasym Ltd., Evren Technologies, Inc., Nemechek Technologies, Neuroloop GmbH, and others.

• gammaCore Sapphire, NEMOS, VITOS, SYMMETRY, VITARIA MODEL 7103, SENTIVA, Microburst Stimulation, AspireSR, Transcutaneous Neurostimulator, Monarch® eTNS® System, vBloc® Maestro®, NeuroPace RNS System, Vivistim™ System, Bioelectronic Medicine, Vagal Nerve Stimulation Catheter System, Parasym™ Device, and others are some of the FDA-approved Vagus Nerve Stimulator devices available in the market.

• The gammaCore device from ElectroCore Inc. is an FDA-approved, hand-held VNS device that can be used at home to treat pain associated with headaches and migraines in adults. In July 2020, the gammaCore Sapphire CV recently received FDA Emergency Use Authorization (EUA) for emergency use in treating adult patients with known or suspected COVID-19 who are experiencing an exacerbation of asthma-related dyspnea and reduced airflow, and for whom approved drug therapies are not tolerated or provide insufficient symptom relief.

• Evren Technologies, Inc. announced on July 26, 2021, that its non-invasive Phoenix® earbud device had received Breakthrough Device Designation from the US Food and Drug Administration for the treatment of Post-traumatic Stress Disorder (PTSD).

• The Vagus Nerve Stimulator market is segmented by Product Type, Application, and End-User.

Request for the Webex demo of the report @ Vagus Nerve Stimulator Market Outlook

The Vagus Nerve Stimulator market report also discusses Vagus Nerve Stimulator market drivers, Vagus Nerve Stimulator market barriers, and unmet medical needs in order to curate the best opportunities and assess the market’s underlying potential.

Vagus Nerve Stimulator: Overview

Vagus Nerve Stimulation (VNS) is a method of stimulating the vagus nerve. VNS was initially approved to treat Drug-Resistant Epilepsy (DRE), a neurological disorder. Because of abnormal electrical discharges in the brain, it causes seizures and involuntary movements of various extremities. Aside from DRE, VNS is used to treat patients with Treatment-Resistant Depression (TRD) who have not responded to four or more adequate treatments.

Vagus Nerve Stimulator Epidemiology Segmentation

The Vagus Nerve Stimulator report proffers epidemiological analysis for the study period 2018-26 in the 7MM segmented into:

• Eligible Patient Population of Treatment-Resistant Depression 

• Eligible Patient Population of Drug-Resistant Epilepsy 

• Eligible Patient Population of Post-Traumatic Stress Disorder

Vagus Nerve Stimulator Market

The Vagus Nerve Stimulator market is segmented by Product Type, Application, and End-User. It has the presence of major Vagus Nerve Stimulator companies such as Electrocore Inc., tVNS Technologies, LivaNova, Soterix Medical, NeuroSigma, ReShape Lifesciences, NeuroPace, Inc., Micro Transponder, and others. The rising prevalence of neurological conditions, as well as patient resistance to antidepressants, are expected to contribute to rising Vagus Nerve Stimulator product demand during the study period (2018-2026).

Find out which player or device is going to get the maximum share @ Vagus Nerve Stimulator Market Size

Vagus Nerve Stimulator Key Companies

• Electrocore Inc.

• tVNS Technologies

• LivaNova

• Soterix Medical

• NeuroSigma

• ReShape Lifesciences

• NeuroPace, Inc.

• Micro Transponder

• SetPoint Medical Corporation

• Neuroceuticals

• Parasym Ltd.

• Evren Technologies, Inc.

• Nemechek Technologies

• Neuroloop GmbH

Vagus Nerve Stimulator Market Drivers

• Increased incidence of neurological disorders such as epilepsy, migraine, and others

• Growing patients with resistant epileptic seizures

• Technological advancements in product development

Vagus Nerve Stimulator Market Barriers

• The dearth of skilled professionals

• Side effects associated with the devices

• High cost of the devices

Vagus Nerve Stimulator Unmet Needs

• Lack of adequate safety and efficacy results

• Lack of reimbursement policy for vagus nerve stimulation therapy

• Limited to resistant epilepsy and treatment-resistant depression

Scope for the Report

Coverage: 7MM (the US, EU5 (the UK, Germany, Italy, Spain, and France) and Japan)

Study Period: 2018-26

Vagus Nerve Stimulator Key Companies: Electrocore Inc., tVNS Technologies, LivaNova, Soterix Medical, NeuroSigma, ReShape Lifesciences, NeuroPace, Inc., Micro Transponder, SetPoint Medical Corporation, Neuroceuticals, Parasym Ltd., Evren Technologies, Inc., Nemechek Technologies, Neuroloop GmbH,among others. 

Porter’s Five Forces Analysis

KOL’s Views

Table of Contents

For rich insights into Healthcare and Pharmaceutical News, visit Pharma, Healthcare, and Biotech Blog Posts

Related Reports

Sacral Nerve Stimulation Market

Get a comprehensive analysis of Sacral Nerve Stimulation Market pipeline devices and key companies including Medtronic Plc, Boston Scientific Corporation, St. Jude Medical, Cyberonics, Neuropace, Synapse Biomedical, Uroplasty, Inc, Codman & Shurtleff, Inc, IntraPace, Inc, among others.

About DelveInsight

DelveInsight is a leading Business Consultant and Market Research firm focused exclusively on life sciences. It supports Pharma companies by providing end-to-end comprehensive solutions to improve their performance.

Media Contact
Company Name: DelveInsight Business Research LLP
Contact Person: Sandeep Joshi
Email: Send Email
Phone: 9193216187
Address:304 S. Jones Blvd #2432
City: Las Vegas
State: NV
Country: United States
Website: www.delveinsight.com/